ArticleInternational journal of oncology2014

Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3-kinase inhibitor (ZSTK474).

Lehang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.